QuidelOrtho Corporation logo

QuidelOrtho Corporation

QDEL | NASDAQ
Chart Builder DCF Calculator
$10.86
+$0.24 (+2.26%)
At close: Sep 21, 2026, 4:00 PM ET
$10.86
$0 (0.00%)
Pre-market: Sep 22, 2026, 4:00 AM ET

Company Profile

QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression. The Transfusion Medicine unit focuses on ensuring blood safety and compatibility by offering immunohematology and infectious disease screening tests for blood and plasma. For rapid results in various clinical environments, the Point-of-Care segment delivers quick diagnostic tests. Additionally, the Molecular Diagnostics arm develops advanced polymerase chain reaction thermocyclers, analyzers, and amplification systems. QuidelOrtho distributes its offerings both directly to end-users and through an extensive network of distributors. These products are utilized by professionals in settings such as medical offices, hospitals, clinical and reference laboratories, urgent care centers, universities, retail clinics, pharmacies, wellness screening centers, and blood/donor banks, as well as for individual, non-professional, and over-the-counter applications. Founded in 1979 and based in San Diego, California, the company maintains a global footprint, including operations across North America, Europe, the Middle East, Africa, and China.

Key Executives

Name Position
Brian J. Blaser President, Chief Executive Officer & Director
Jonathan Siegrist Executive Vice President of Research & Development and Chief Technology Officer
Micah Young Chief Financial Officer & Principal Financial Officer
Nathaniel Sisitsky Chief Legal Officer & Corporate Secretary
Andrew Corkum Senior VP and Head of EMEA & LATAM
Audra Jones Senior VP & Head of North America
Bryan Hanson Executive VP of Global Portfolio Management and Marketing
Erich Wolff Executive Vice President of Strategy & Corporate Development
Iris Lin Head of JAPAC (Japan, ASPAC & China)
Juliet C. Cunningham Vice President of Investor Relations
Lisa S. Hayes Vice President of Global Marketing & Corporate Communications
Philip McLellan Chief Operations Officer
Ronald Lee Bowman Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Aug 18, 2026 4 Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 13, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 07, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Aug 05, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jul 16, 2026 4 Filing
Jul 15, 2026 3 Filing
Jul 13, 2026 S-8 Filing
View All SEC Filings
QuidelOrtho Corporation
QuidelOrtho Corporation logo
Country United States
IPO Date Jan 31, 1991
Industry Medical - Specialties
Sector Healthcare
Employees 6,500
CEO Brian J. Blaser

Contact Details

9975 Summers Ridge Road San Diego, California 92121 United States

Stock Details

Ticker Symbol QDEL
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001906324
CUSIP Number 219798105
ISIN Number US2197981051
SIC Code 2835

© 2026 bestshares.com. All rights reserved.